Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: Quest for specific inhibition of inosine monophosphate dehydrogenase

Pharmacology and Therapeutics

Volumn 76, Issue 1-3, 1997, Pages 89-100

  Pankiewicz, Krzysztof W ^a  

^a Division of Medicinal Chemistry   (United States)

Author keywords

Anticancer; IMPDH inhibitors; NAD analogues

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; INOSINATE DEHYDROGENASE; MEDRONIC ACID DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE DERIVATIVE; SELENAZOFURIN; SELENAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER; CELL DIFFERENTIATION; CELL STRAIN K 562; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; HUMANS; IMP DEHYDROGENASE; NAD; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031277790     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00092-2     Document Type: Review

References (66)

1. Bergstrom, D. E. and Swarding, D. J. (1988) Fluorine substituted analogs of nucleic acid components. In: Fluorine Containing Molecules, Structure, Reactivity, Synthesis, and Applications, pp. 259-308, Liebman, J. F., Greenberg, A. and Dolbier W. R., Jr. (eds.) VCH Publishers, New York.
2. Blackburn, G. M., Eckstein, F., Kent, D. E. and Perree, T. D. (1985) Isopolar vs. isosteric phosphonate analogues of nucleotides. Nucleosides Nucleotides 4: 165-167.
3. Bourne, H. R., Sanders, D. A. and McCormic, F. (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349: 117-127.
4. Burling, T. F. and Goldstein, B. M. (1992) Computational studies of nonboncled sulfur-oxygen and selenium-oxygen interactions in the thiazole and selenazole nucleosides. J. Am. Chem. Soc. 114: 2313-2320.
5. Carr, S. F., Papp, E., Wu, J. C. and Natsumeda, Y. (1993) Characterization of human type I and type II IMP dehydrogenase. J. Biol. Chem. 268: 27286-27290.
6. Cooney, D. A., Jayaram, H. N., Glazer, R. A., Kelly, J. A., Marquez, V. E., Gebeyehu, G., van Cott, A. C., Zwelling, L. A. and Johns, D. G. (1983) Studies on the mechanism of action of tiazoturin metabolism to an analog of NAD with potent IMP dehydrogenase inhibitory activity. Adv. Enzyme Regul. 21: 271-303.
7. Eklund, H. and Branden, C. I. (1987a) Active sites of enzymes. In Biological Macromolecules and Assemblies, Vol. 3, Ch. 2, pp. 74-142, Jurnak, F. A. and McPherson, A. (eds.) Wiley, New York.
8. Eklund, H. and Branden, C. I. (1987b) Crystal structure, coenzyme conformations, and protein interactions. In Pyridine Nucleotide Coenzymes, pp. 74-85, Dolphin, D., Avramovic, O. and Poulson, R. (eds.) Wiley, New York.
9. Franklin, T. J., Edwards, G. and Hedge, P. (1995) Inosine 5′-monophosphate dehydrogenase as a chemotherapeutic target. In: Purine and Pyrimidine Metabolism in Man VIII pp. 155-160, Sahota, A. and Taylor, M. (eds.) Plenum Press, New York.
10. Franklin, T. J., Jacobs, V., Jones G., Ple, P. and Bruneau, P. (1996) Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res. 56: 984-987.
11. Gebeyehu, G., Marquez, V. E., Kelly, J. A., Cooney, D. A., Jayaram, H. N. and Johns, D. G. (1983) Synthesis of thiazole-4-carboxamide adenine dinucleotide. J. Med. Chem. 26: 922-925.
12. Gebeyehu, G., Marquez, V. E., Van Cott, A., Cooney, D. A., Kelly, J, A., Jayaram, H. N., Ahluwalia, G. S., Dion, R. L., Wilson, Y. A. and Johns, D. G. (1985) Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues; synthesis. structure, and interactions with IMP dehydrogenase. J. Med. Chem. 28: 99-105.
13. Gharehbaghi, K., Paull, K. D., Kelley, J. A., Barchi, J. J., Jr., Marquez, V. E., Cooney, D. A., Monks, A., Scudiero, D., Krohn, K. and Jayaram, H. N. (1994) Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase. Int. J. Cancer 56: 892-899.
14. Gibbs, J. B., Marshal, M., Scolnic, E. M., Dixon, R. F. and Vogel, J. (1990) Modulation of guanine nucleotides bound to Ras in NIHI3T3 cells by oncogenes, growth factors, and GTPase activating protein (GAP). J. Biol. Chem. 265: 20473-20442.
15. Goldstein, B. M., Mao, D. T. and Marques, V. E. (1988) Ara-tiazolurin: conservation of structural features in an unusual thiazole nucleoside. J. Med. Chem. 11: 1026-1031.
16. Goldstein, B. M., Leary, J. F., Farlev, B. A., Marquez, V. E., Levy, P. C. and Rowley, P. T. (1991) Induction of HL60 cell differentiation by tiazofurm and its analogues: characterization and efficacy. Blood 78: 593-598.
17. Goldstein, B. M., Li, H., Jones, J. P., Ellis Bell, J., Zeidler, J., Pankiewicz, K. W. and Watanabe, K. A. (1994) CNAD: a potent and specific inhibitor of alcohol dehydrogenase, J. Med. Chem. 37: 392-399.
18. Grau, W. M. (1982) Structural interactions with enzymes. In: The Pyridine Nucleotide Coenzymes, pp. 135-187, Anderson, B. M., Everse, J. and You, K.-S. (eds.) Academic Press, New York.
19. Herken, H. (1971) Antimetabolic action of 6-aminonicotinamide on the pentose pathway in the brain. In: Mechanism of Toxicity, pp. 189-203, Aldridge, W. N. (ed.) McMillan, London.
20. Huberman, E., Glesne, D. and Collart, F. (1995) Regulation and role of inosine-5′-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation. In: Advances in Experimental Medicine and Biology, Purine and Pyrimidine Metabolism in Man VIII, Vol. 370, pp. 741-746, Sahota, A. and Taylor, M. (eds.) Plenum Press, New York.
21. Ishihama, A., Enami, M., Nishijama, Y., Fukui, T., Otsuka, E. and Ikehara, M. (1980) 2′-Deoxy-2′-azidoadenosine triphosphate and 2′-deoxy-2′-fluoroadenosine triphosphate as substrates and inhibitors for Escherichia coli DNA-dependent: RNA polymerase. J. Biochem. 87: 825-830.
22. Jackson, R. C., Weber, G. and Morris, H. P. (1975) IMP-dehydrogenase: an enzyme linked with proliferation and malignancy. Nature 256: 331-333.
23. Jayaram, H. N., Lapis, E., Tricot, G., Kneebone, P., Paulik, E., Zhen, W., Engeler, G. P., Hoffman, R. and Weber, G. (1992) Clinical pharmacokinetics study of tiazofurin administered as 1-hour infusion. Int. J. Cancer 51: 182-188.
24. Joos, P. E., Esmans, E. L., Dommisse, R. A., Van Dongon, W., Lepoivre, J. A., Alderweireldt, F. C., Balzarini, J. and De Clerg, E. (1991) Synthesis and biological evaluation of carbamoyl-2-β-D-ribofuranosylpyridine. Nucleosides Nucleotides 10: 883-894.
25. Kabat, M. M., Pankiewicz, K. W., Sochacka, E. and Watanabe, K. A. (1988) Synthesis of 6-(β-D-ribofuranosyl)picolinamide: a novel C-nucleoside from D-ribonolactone. Chem. Pharm. Bull. 36: 634-640.
26. Koide, S., Yokoyama, S., Matsuzawa, H., Miyazawa, T. and Ohta, T. (1989) Conformation of NAD+ bound to allosteric L-lactate dehydrogenase activated by chemical modification. J. Biol. Chem. 264: 8676-8679.
27. Krohn, K., Heins, H. and Wielckens, K. (1992) Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogues. J. Med. Chem. 35: 511-517.
28. Lesiak, K., Watanabe, K. A., Majumdar, A., Seidman, M., Venderveen, K., Goldstein, B. M. and Pankiewicz, K. W. (1997) Synthesis of non-hydrolyzable analogues of thiazole-4-carboxamide- and benzamide-adenine dinucleotide containing fluorine atom at the C2′ of adenine nucleoside: induction of K562 differentiation and IMPDH inhibitory activity. J. Med. Chem. 40: 2533-2538.
29. Li, H., Hallows, W. A., Punzi, J. S., Marquez, V. E., Carrel, H. L., Pankiewicz, K. W., Watanabe, K. A. and Goldstein, B. M. (1994a) Crystallographic studies of two alcohol dehydrogenase-bound analogs of thiazole-4-carboxainide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin. Biochemistry 33: 23-32.
30. Li, H., Hallows, W. H., Punzi. J. S., Pankiewicz, K. W., Watanabe, K. A. and Goldstein, B. M. (1994b) Crystallographic studies of isosteric NAD analogues bound to alcohol dehydrogenase: specificity and substrate binding in two ternary complexes. Biochemistry 33: 11734-11744.
31. Liao, H.-J. and Stollar, V. (1993) Reversal of the antiviral activity of ribavirin against Sindbis virus in Ae albopictus mosquito cells. Antiviral Res. 22: 285-289.
32. Lipka, P., Zatorski, A., Watanabe, K. A. and Pankiewicz, K. W. (1996) Synthesis of methylene bridged analogues of necorinamide rihoside, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide. Nucleosides Nucleotides 15: 149-167.
33. Makara, G. M., Keseru, G. M., Kajtar-Peredy, M. and Anderson, W. K. (1996) Nuclear magnetic resonance and molecular modeling study on mycophenolic acid: implications for binding to inosine monophosphate dehydrogenase. J. Med. Chem. 39: 1236-1242.
34. Marques, V. E., Tseng, C. K. H., Gebeyehu, G., Cooney, D. A., Ahluwalia, G. S., Kelly, J. A., Dalal, M., Fuller, R. W., Wilson, Y. A. and Johns, D. G. (1986) Thiazole-4-carboxamide adenine dinucleoride (TAD): analogues stable to phosphodiesterase hydrolysis. J. Med. Chem. 29: 1726-1731.
35. Mayer, T., Wielckens, K., Thiem, J. and Hiltz, U. (1984) NAD(S), an NAD analogue with reduced susceptibility to phosphodiesterase: chemical synthesis and enzymic properties. Eur. J. Biochem. 140: 531-537.
36. Minakawa, N., Takeda, T., Sasaki, T., Matsuda, A. and Ueda, T. (1991) Synthesis and antitumor activity of 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives. J. Med. Chem. 34: 778-786.
37. Nagai, M., Natsumeda, Y. and Weber, G, (1991) Proliferation-linked regulation of type II 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res. 52: 3886-3890.
38. 2H]NADH by dehydrosenases. J. Biol. Chem. 261: 12209-12212.
39. Pankiewicz, K. W. and Watanabe, K. A. (1993a) A synthesis of 2′-fluoro- and 3′-fluoro-substituted purine nucleusides via direct approach. In: Nucleosides and Nucleotides as Antitumor and Antiviral Agents, pp. 55-71, Chu, C. K. and Baker, D. C. (eds.) Plenum Press, New York.
40. Pankiewicz, K. W. and Watanabe, K. A. (1993b) Synthesis of 2′-β-fluoro-substituted nucleosides by a direct approach. J. Fluor. Chem. 64: 14-36.
41. Pankiewicz, K. W., Sochacka, E., Kabat, M. M., Ciszewski, L. A. and Watanabe, K. A. (1988) Efficient synthesis of 5-(β-D-ribofuranosyl)nicotinamide and its α-isomer. J. Org. Chem. 53: 3473-3479.
42. Pankiewicz, K. W., Ciszewski, L. A. and Ptak, A. T. (1991) Synthesis of 2,2′-anhydro-2-hydroxy- and 6,2′-anhydro-6-hydroxy-1-β-D-arabinofuranosyl nicotinainide as conformationally restricted nicotinamide nucleoside analogs. Nucleosides Nucleotides 10: 1333-1344.
43. Pankiewicz, K. W., Krzeminski, J., Ciszewski, L. A., Ren, W-Y. and Watanabe, K. A. (1992a) A synthesis of 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine and hypoxanthine an effect of C3′-endo to C2′-endo conformational shirt on the reaction course of 2′-hydroxyl group with DAST. J. Org. Chem. 57: 553-559.
44. Pankiewicz, K. W., Krzeminski, J. and Watanabe, K. A. (1992b) Synthesis of 2′-β-fluoro- and 3′-α-fluoro-substituted guanine nucleosides: effects of sugar conformational shifts on nucleophilic displacement of the 2′-hydroxy and 3′-hydroxy group with DAST. J. Org. Chem. 57: 7315-7321.
45. Pankiewicz, K. W., Zeidler, J., Ciszewski, L. A., Bell, J. E., Goldstein, B. M., Jayaram, H. N. and Watanabe, K. A. (1993) Synthesis of isosteric analogues of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide and picolinamide. J. Med. Chem. 36: 1855-1859.
46. 2-disubstituted pyrophosphates of biological interest A novel plausible mechanism. J. Am. Chem. Soc. 119: 3691-3695.
47. Pankiewicz, K. W., Lesiak, K., Zarorski, A., Goldstein, B. M., Carr, S. F., Sochacki, M., Majumdar, A., Seidman, M. and Watanabe, K. A. (1997b) The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II). J. Med. Chem. 40: 1287-1291.
48. Robins, R. K. (1982) Nucleoside and nucleotide inhibitors of inosine monophosphate dehydrogenase (IMP) as potential antitumor inhibitors. Nucleosides Nucleotides 1: 35-44.
49. Sherley, J. L. (1991) Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem. 266: 24815-24828.
50. Sinnott, M. L. (1988) Least nuclear motion and stereoelectronic control. In: Advances in Physical Organic Chemistry, Vol. 24, pp. 135-139, Bethell, D. (ed.) Academic Press, London.
51. Sintchak, M. D., Fleming, M. A., Futer, O., Raybuck, S. A., Chambers, S. P., Caron, P., Murcko, M. A. and Wilson, K. P. (1996) Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 85: 921-930.
52. 4 analogues containing a 2′-deoxy-2′-substituted nicotinamide arabinofunanosyl moiety. J. Org. Chem. 56: 3608-3613.
53. Stoeckler, J. D., Bell, C. A., Parks, R. E., Jr., Chu, C. K., Fox, J. J. and Ikehara, M. (1982) C(2′)-substituted purine nucleoside analogs. Biochem. Pharmacol. 31: 1723-1728.
54. Tsutani, H., Inai, K., Imamura, S., Ueda, T. and Nakamura, T. (1995) Induction of cell differentiation by IMPDH antisense oligomer in HL-60 and K562 human leukemia cell lines. In: Advances in Experimental Medicine and Biology, Purine and Pyrimidine Metabolism in Man VIII, Vol. 370, pp. 757-760. Sahota, A. and Taylor, M. (eds.) Plenum Press, New York.
55. Uesugi, S., Miki, M., Ikehara, H., Iwahashi, Y. and Kyogoku, A. (1979) A linear relationship between electronegativttv of 2′-substitutents and conformation of adenine nucleosides. Tetrahedron Lett.: 4073-4076.
56. Uesugi, S., Kaneyasu, T., Matsugi, J. and Ikehara, M. (1983) Improved synthesis of 2′-fluoro-2′-deoxyadenosine and synthesis and carbon-13 NMR spectrum of its 3′,5′-cyclic phosphate derivative. Nucleosides Nucleotides 2: 373-385.
57. Van Aerschot, A., Balzarini, J., De Clercq, E. and Herdewijn, P. (1989a) Synthesis of 3′-fluoro-3′-deoxyribonucleosides: anti HIV-1 and cytostatic properties. Nucleosides Nucleotides 8: 1123-1124.
58. Van Aerschot, A., Herdewijn, P., Janssen, G., Cools, M. and De Clercq, E. (1989b) Synthesis and antiviral activity evaluation of 3′-fluoro-3′-deoxyribonucleosides: broad-spectrum antiviral activity of 3′-fluoro-3′-deoxyadenosme. Antiviral Res. 12: 133-150.
59. Veres, Z., Szablocs, A., Szinai, I., Denes, G., Kajtar-Peredy, M. and Otvos, L. (1985) 5-Substituted-2,2′-anhydrouridines: potent inhibitors of uridine phosphorylase: Biochem. Pharmacol. 34: 1757-1740.
60. Wang, W., Papov, V. V., Minakawa, N., Matsuda, A., Bieman, K. and Hedstrom, L. (1996) Inactivation of inosine 5′-monophosphale dehydrogenase by the antiviral agent 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide 5′-monophosphate. Biochemistry 35: 95-101.
61. Weber, G., Prajda, N. and Jackson, R. C. (1986) Enzymes of IMP metabolism: transformation- and proliferation-linked alterations in gene expression. Adv. Enzyme Regul. 14: 3-12.
62. Westheimer, F. W. (1987) Mechanism of action of the pyridine nucleotides. In: Pyridine Nucleotide Coenzymes, Part A, pp. 255-321, Dolophin, D., Avramovic, O. and Poulson, R. (eds.) Wiley, New York.
63. Woenckhaus, C. and Jeck, R. (1987) Preparation and properties of NAD and NADP analogs. In: Pyridine Nucleotide Coenzymes, Part A, pp. 533-540, Dolphin, D., Avramovic, O. and Poulson, R. (eds.) Wiley, New York.
64. Wu, J. C. (1994) Mycophenolate mofetil: molecular mechanism of action. In: Perspectives in Drug Discovery and Design, Vol. 2, pp. 185-204, Wyvratt, M. J. and Sigal, N. H. (eds.) ESCOM Science Publisher, Leiden.
65. Zatorski, A., Lipka, P., Mollova, N., Schram, K. H., Goldstein, R. M., Watanabe, K. A. and Pankiewicz, K. W. (1993) Synthesis of thiazole-4-carboxamide adenine ditluoromethylenediphosphonates substituted with fluorine at C-2′ of the adenosine. Carbohydr. Res. 249: 95-108.
66. Zatorski, A., Watanabe, K. A., Carr, S. F., Goldstein, B. M. and Pankiewicz, K. W. (1996) Chemical synthesis ot benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II). J Med. Chem. 39: 2422-2426.